NASDAQ:PHH - Nasdaq - KYG6925R1020 - Common Stock - Currency: USD
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.
We recently published a list of Why These 15 Consumer Defensive Stocks Are Surging in 2025. In this article, we are going to take a look at where Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) stands against other consumer defensive stocks that are surging in 2025. The stock market has taken a sharp turn after […]
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Tiziana Life Sciences Ltd (NASDAQ:TLSA) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making […]
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing...
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the
Randal Quarles, the Federal Reserve's vice chair for supervision, says regulators need to be vigilant about new risks from lenders that operate outside of the strictest banking-industry rules - as well as from the increasing push by technology companies into lending and asset management.
PHH – Reports Q2 EPS loss of $1.11 and revenue of $35M (+12.9% Y/Y).
The court is expected to address the constitutionality of the Consumer Financial Protection Bureau and whether companies are allowed to discriminate based on sexual orientation.
PHH – Reports Q1 EPS loss of $0.80. Misses on revenues.
Mentions: OCN